Loading clinical trials...
Loading clinical trials...
The MecoExpo project seeks to evaluate the in utero exposure of newborns in the Picardie region to commonly used pesticides. These pesticides were selected in a pilot study (the Mecopic study) on the basis of their toxicity (effects on foetal development, endocrine perturbation, neurological toxicity and carcinogenicity) and a certain number of indicators of pesticide use and the presence of pesticide in the environment in Picardie. These substances (or their metabolites) will be measured in the each newborn's meconium (the first faeces after birth) and each newborn's mother's hair in the Picardie region during the study period. The mother's exposure will also be assessed using a retrospective questionnaire (filled out within a few days of the delivery). Thus, the MecoExpo project will enable the investigators to: 1. evaluate the relationships between foetal exposure (via the meconium), maternal exposure (via the hair and the questionnaire) and clinical parameters measured at birth (term, length, weight, etc.). 2. map pesticide exposure across the Picardie region. 3. create a meconium bank in Picardie (the first ever meconium bank in France).
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
CH Abbeville
Abbeville, France
CHU Amiens
Amiens, France
Groupe Santé Victor Pauchet
Amiens, France
CH Beauvais
Beauvais, France
CH Chauny
Chauny, France
CH Chateau-Thierry
Château-Thierry, France
Clinique Saint Come
Compiègne, France
CH Compiegne
Compiègne, France
Groupe Hospitalier Public Sud Oise
Creil, France
CH Laon
Laon, France
Start Date
February 1, 2011
Primary Completion Date
February 1, 2015
Completion Date
February 1, 2015
Last Updated
September 19, 2025
1,020
ACTUAL participants
meconium
OTHER
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06750796